CSF biomarkers in patients with epilepsy in Alzheimer’s disease: a nation-wide study

Alzheimer’s disease is the most common neurodegenerative dementia. A subset of Alzheimer’s disease patients develop epilepsy. The risk is higher in young-onset Alzheimer’s disease, but pathophysiological mechanisms remain elusive. The purpose of this study was to assess biomarkers reflecting neurode...

Descripción completa

Detalles Bibliográficos
Autores principales: Banote, Rakesh Kumar, Håkansson, Samuel, Zetterberg, Henrik, Zelano, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419062/
https://www.ncbi.nlm.nih.gov/pubmed/36043137
http://dx.doi.org/10.1093/braincomms/fcac210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419062/
https://www.ncbi.nlm.nih.gov/pubmed/36043137
http://dx.doi.org/10.1093/braincomms/fcac210

Ejemplares similares